Mollie Leoni, Chief Medical Officer at Kura Oncology, Inc. (KURA), sold 84,929 shares at $9.82 ($834K) on 2026-06-18, disclosed to the SEC on 2026-06-22.
Scheduled sale ($834k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| KURA | SELL | 2025-11-14 | $346K | — | Filing → |
| KURA | SELL | 2025-09-29 | $220K | — | Filing → |
| KURA | SELL | 2025-01-28 | $39K | — | Filing → |